The discovery of imidazo[4,5-c]pyridine-2-ones as selective inhibitors of DNA-dependent protein kinase and effective radiosensitisersEUROPEAN JOURNAL OF CANCERIF7.12024-10-010PRE
Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as RadiosensitizersJOURNAL OF MEDICINAL CHEMISTRYIF6.82024-07-150OAAI
Targeting tumor hypoxia with prodrugs of DNA-dependent protein kinase inhibitorsCANCER RESEARCHIF16.62024-01-090PRE
Design, Synthesis and Anticancer Evaluation of Nitroimidazole RadiosensitisersMOLECULESIF4.62023-05-312OAAI
Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361BIOCHEMICAL PHARMACOLOGYIF5.62019-11-0124PREAI
Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated ProdrugsCLINICAL ONCOLOGYIF32019-05-0125PREAI
Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole AlkylsulfonamidesJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-01-1154PREAI
Chemical Space Mimicry for Drug DiscoveryJOURNAL OF CHEMICAL INFORMATION AND MODELINGIF5.32017-04-0361OAAI
Synthesis and in vitro and in vivo evaluation of antimalarial polyaminesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-11-0122OAAI